Inovio Pharmaceuticals, Inc. (INO): Cash & Equivalents
$44.27M
As of 2025-12-31
$31.53M
As of 2026-06-30
-1.5%
3-year compound annual growth
-29.3%
5-year compound annual growth
-2.6%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $44.27M | -32.7% | 2026-03-12, Balance as of period end |
| 2024-12-31 | $65.81M | +359.9% | 2026-03-12, Balance as of period end |
| 2023-12-31 | $14.31M | -69.1% | 2025-03-18, Balance as of period end |
| 2022-12-31 | $46.33M | -34.9% | 2024-03-06, Balance as of period end |
| 2021-12-31 | $71.14M | -71.6% | 2023-03-01, Balance as of period end |
| 2020-12-31 | $250.73M | n/m | 2022-03-01, Balance as of period end |
| 2019-12-31 | $22.20M | -6.3% | 2021-03-01, Balance as of period end |
| 2018-12-31 | $23.69M | -0.4% | 2020-03-12, Balance as of period end |
| 2017-12-31 | $23.79M | +24.3% | 2019-03-12, Balance as of period end |
| 2016-12-31 | $19.14M | -66.8% | 2019-03-12, Balance as of period end |
| 2015-12-31 | $57.63M | +42.1% | 2018-03-14, Balance as of period end |
| 2014-12-31 | $40.54M | +20.2% | 2017-03-15, Balance as of period end |
| 2013-12-31 | $33.72M | +497.2% | 2016-03-14, Balance as of period end |
| 2012-12-31 | $5.65M | -67.5% | 2015-03-16, Balance as of period end |
| 2011-12-31 | $17.35M | -13.2% | 2014-03-17, Balance as of period end |
| 2010-12-31 | $20.00M | -34.0% | 2013-03-18, Balance as of period end |
| 2009-12-31 | $30.30M | n/a | 2012-03-15, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $44.27M | -32.7% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $38.34M | -51.0% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $4.75M | +21.6% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $15.86M | -88.2% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $1.95M | -58.2% |
| Incannex Healthcare Inc. (IXHL) | 2025-06-30 | $15.04M | +156.7% |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $48.00M | -34.2% |
| iBio, Inc. (IBIO) | 2026-06-30 | $56.40M | +557.1% |
| Altimmune, Inc. (ALT) | 2025-12-31 | $43.76M | +18.5% |
Compare INO, CNTB, SILO, AVTX side by side · Screen every company in Pharmaceutical Preparations ↗